Tower Research Capital LLC (Trc) Meridian Bioscience Inc Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$31.15 - $33.39 $25,667 - $27,513	-824 Reduced 24.55%	2,533 $84,000
Q3 2022 Nov 10, 2022	BUY	$30.9 - $33.55 $61,645 - $66,932	1,995 Added 146.48%	3,357 $106,000
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $94,287 - $125,809	-3,970 Reduced 74.46%	1,362 $41,000
Q1 2022 May 12, 2022	BUY	$19.97 - $26.94 $102,246 - $137,932	5,120 Added 2415.09%	5,332 $138,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $10,179 - $12,598	-583 Reduced 73.33%	212 $4,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $19,761 - $25,627	-1,139 Reduced 58.89%	795 $15,000
Q2 2021 Aug 16, 2021	SELL	$18.01 - $28.32 $98,478 - $154,853	-5,468 Reduced 73.87%	1,934 $43,000
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $80,067 - $121,114	4,052 Added 120.96%	7,402 $195,000
Q4 2020 Feb 16, 2021	SELL	$15.73 - $21.66 $542,040 - $746,381	-34,459 Reduced 91.14%	3,350 $62,000
Q3 2020 Nov 16, 2020	BUY	$13.54 - $26.41 $435,757 - $849,953	32,183 Added 572.04%	37,809 $642,000
Q2 2020 Aug 13, 2020	BUY	$7.84 - $23.29 $44,107 - $131,029	5,626 New	5,626 $131,000
Q4 2019 Feb 07, 2020	SELL	$7.9 - $10.14 $9,100 - $11,681	-1,152 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$9.17 - $12.01 $10,563 - $13,835	1,152 New	1,152 $11,000
Q2 2019 Aug 13, 2019	SELL	$10.88 - $17.6 $2,632 - $4,259	-242 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $3,753 - $4,261	242 New	242 $4,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $42,655 - $50,074	-3,091 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$13.55 - $15.8 $16,720 - $19,497	-1,234 Reduced 28.53%	3,091 $44,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $58,171 - $62,063	4,325	4,325 $61,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account